<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">From the cellular level to the population level, HIV modelling has led to improvements in drug formulations, clinical care and resource allocation. As scientific advances continue to bring pharmaceutical innovations, modelling will remain a useful tool for illuminating transmission dynamics and optimizing public health policy.</p>
